We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
-15.01%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$31.8B
AUM Growth
-$7.3B
(-19%)
Cap. Flow
-$363M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
23.56%
Holding
999
New
22
Increased
368
Reduced
528
Closed
49
Avg Time Held
3.4
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$175M |
| 2 |
Banco Santander Chile
BSAC
|
+$99.6M |
| 3 |
Royalty Pharma
RPRX
|
+$54.4M |
| 4 |
Charles Schwab
SCHW
|
+$50.5M |
| 5 |
Darling Ingredients
DAR
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$181M |
| 2 |
NextEra Energy
NEE
|
+$167M |
| 3 |
Huntington Bancshares
HBAN
|
+$166M |
| 4 |
AbbVie
ABBV
|
+$88.9M |
| 5 |
PayPal
PYPL
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.22% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Telefônica Brasil
VIV
$19.6B
| $20.6M | 0.06% |
2,339,100
-17,800
| -0.8% | -$183K |
2017 Q4
18 quarters
|
|
277
Vodafone
VOD
$36.7B
| $20.6M | 0.06% |
1,323,500
-111,500
| -8% | -$1.78M |
2019 Q4
10 quarters
|
|
278
Health Catalyst
HCAT
$135M
| $20.6M | 0.06% |
1,422,201
-20,383
| -1% | -$348K |
2021 Q2
4 quarters
|
|
279
Progressive
PGR
$124B
| $20.4M | 0.06% |
178,333
-12,206
| -6% | -$1.38M |
2017 Q3
19 quarters
|
|
280
Americold
COLD
$3.97B
| $20.4M | 0.06% |
682,217
+622,655
| +1,045% | +$17.3M |
2019 Q1
13 quarters
|
|
281
Cognizant
CTSH
$29.6B
| $20.2M | 0.06% |
298,152
-53,660
| -15% | -$4.11M |
2017 Q3
19 quarters
|
|
282
Equity Lifestyle Properties
ELS
$11.7B
| $20.1M | 0.06% |
283,108
-9,046
| -3% | -$675K |
2017 Q3
19 quarters
|
|
283
Ranpak Holdings
PACK
$298M
| $20.1M | 0.06% |
2,702,217
+1,000,913
| +59% | +$12.9M |
2021 Q2
4 quarters
|
|
284
DELISTED
ChampionX
CHX
| $20.1M | 0.06% |
1,010,373
+360,119
| +55% | +$8.14M |
2022 Q1
1 quarter
|
|
285
SITE Centers
SITC
$158M
| $20M | 0.06% |
1,873,848
+705,876
| +60% | +$8.33M |
2019 Q2
12 quarters
|
|
286
Hormel Foods
HRL
$11.1B
| $20M | 0.06% |
421,204
+293,852
| +231% | +$14.7M |
2017 Q3
19 quarters
|
|
287
VF Corp
VFC
$6.68B
| $19.8M | 0.06% |
447,837
+24,091
| +6% | +$1.21M |
2017 Q3
19 quarters
|
|
288
T-Mobile US
TMUS
$168B
| $19.7M | 0.06% |
146,026
+3
| +0% | +$391 |
2017 Q3
19 quarters
|
|
289
Consolidated Edison
ED
$40.6B
| $19.7M | 0.06% |
207,224
+40,019
| +24% | +$3.81M |
2017 Q3
19 quarters
|
|
290
Humana
HUM
$51.9B
| $19.7M | 0.06% |
41,914
+1,547
| +4% | +$688K |
2017 Q3
19 quarters
|
|
291
AstraZeneca
AZN
$259B
| $19.6M | 0.06% |
148,443
-14,855
| -9% | -$1.95M |
2020 Q1
9 quarters
|
|
292
Duke Energy
DUK
$92.7B
| $19.6M | 0.06% |
183,605
-6,851
| -4% | -$753K |
2017 Q3
19 quarters
|
|
293
Regeneron Pharmaceuticals
REGN
$82B
| $19.2M | 0.06% |
32,299
+3,830
| +13% | +$2.49M |
2017 Q3
19 quarters
|
|
294
DELISTED
Ansys
ANSS
| $18.9M | 0.06% |
78,177
-16,760
| -18% | -$4.43M |
2017 Q3
19 quarters
|
|
295
XPLR Infrastructure LP
XIFR
$926M
| $18.8M | 0.06% |
+254,756
| New | +$18.3M |
2022 Q2
0 quarters
|
|
296
Agilent Technologies
A
$49.5B
| $18.8M | 0.06% |
158,314
+12,479
| +9% | +$1.53M |
2017 Q3
19 quarters
|
|
297
DELISTED
American Equity Investment Life Holding Company
AEL
| $18.8M | 0.06% |
+517,688
| New | +$19.7M |
2022 Q2
0 quarters
|
|
298
Sherwin-Williams
SHW
$81.8B
| $18.7M | 0.06% |
83,887
+3,772
| +5% | +$968K |
2017 Q3
19 quarters
|
|
299
Prudential Financial
PRU
$40.1B
| $18.7M | 0.06% |
194,999
+34,664
| +22% | +$3.67M |
2017 Q3
19 quarters
|
|
300
Intuitive Surgical
ISRG
$151B
| $18.6M | 0.06% |
92,394
-2,219
| -2% | -$521K |
2017 Q3
19 quarters
|
|
Similar funds
Aberdeen Group's Q2 2022 Portfolio in Review
As of Q2 2022, Aberdeen Group held 999 positions worth $31.8B, down 19% from $39.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aberdeen Group's Q2 2022 filing shows 22 new, 368 increased, 528 reduced and 49 closed positions. Its largest new stake was American Equity Investment Life Holding Company: 517,688 shares worth $18.8M. The largest sale was Meta Platforms (Facebook), an estimated $181M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q2 2022 buy was American Equity Investment Life Holding Company: 517,688 shares worth $18.8M.
- Aberdeen Group added most to Merck in Q2 2022, an estimated $175M increase.
- Aberdeen Group's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $181M.
- Aberdeen Group fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2022, selling an estimated $46.5M.
- Aberdeen Group's ten largest holdings make up 24% of its $31.8B portfolio in Q2 2022.
- Aberdeen Group opened 22 new positions and closed 49 in Q2 2022.
- Aberdeen Group's portfolio value fell 19% quarter-over-quarter to $31.8B.
Based on Aberdeen Group's 13F filing for Q2 2022, filed 5 Aug 2022.